Jennifer Turner
Gerontology · Portland, ORNPI 1598182289
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 207 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 40.7% of the total. Reporting peaked in 2021 at $1,219 and has fallen 82.8% since, to $210 in 2025. Among gerontology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 207 payments — averaging $13.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Biohaven Pharmaceuticals, Inc.$594
- Biohaven Pharmaceutical Holding Company Ltd.$204
- UCB, Inc.$175
- Teva Pharmaceuticals USA, Inc.$139
- Lilly USA, LLC$105
- plus $470 from 14 others
What the payments were for
- Speaking & faculty fees$161%
- Food & beverage$2,83299%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 101 | $1,160 |
| Biohaven Pharmaceuticals, Inc. | 43 | $594 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $204 |
| UCB, Inc. | 13 | $175 |
| Teva Pharmaceuticals USA, Inc. | 8 | $139 |
| Lilly USA, LLC | 6 | $105 |
| Sunovion Pharmaceuticals Inc. | 4 | $60 |
| Eisai Inc. | 3 | $58 |
| Supernus Pharmaceuticals, Inc. | 3 | $56 |
| Kyowa Kirin, Inc. | 2 | $43 |
| Almatica Pharma LLC | 2 | $42 |
| Sanofi | 1 | $40 |
| AstraZeneca | 2 | $38 |
| Lundbeck LLC | 1 | $29 |
| Aurinia Pharma U.S., Inc. | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Acorda Therapeutics, Inc | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $14 |
| MDD US Operations, LLC | 1 | $12 |
How this compares
$2,847 in reported general payments places this provider in the 90th percentile of 53 gerontology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 12 | $76 |
| Lisinopril | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other gerontology in Portland
- Lauren BrownPortland$32K
- Kimberly FlowersPortland$5K
- Molly DavisPortland$3K
- Jennifer GoodrichPortland$2K
- Rhezarie Mae AgtarapPortland$1K
- Marcia WoodburnPortland$754
- Thomas SandersonPortland$549
- Sarah WheelerPortland$385
- Narcy ForakerPortland$370
- Nicole HainleyPortland$237
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.